Comment Comment by throwGuardian 1. Invest 50% in an index fund2. For the short term gains, Gilead sciences, and other antiviral makers, even generic chloroquine & friends, are likely to gain FDA approval for CV.3. Ventilator makers and even CPAP manufacturers are likely to see a massive spike in demandDonate your gains from #2, #3 to needy CV patients/health Care centres parent throwGuardian 6 years ago
2. For the short term gains, Gilead sciences, and other antiviral makers, even generic chloroquine & friends, are likely to gain FDA approval for CV.
3. Ventilator makers and even CPAP manufacturers are likely to see a massive spike in demand
Donate your gains from #2, #3 to needy CV patients/health Care centres